Primary diffuse large B-cell lymphoma of bone displays preferential rearrangements of the c-MYC or BCL2 gene

被引:20
|
作者
Lima, Francisco Pignataro [1 ,2 ,4 ,5 ]
Bousquet, Marina [1 ,2 ]
Gomez-Brouchet, Anne [3 ]
de Paiva, Geisilene Russano [3 ]
Amstalden, Eliane Maria Ingrid [5 ]
Soares, Fernando Augusto [6 ]
Dastugue, Nicole [1 ,2 ]
Vassallo, Jose [5 ]
Brousset, Pierre [1 ,2 ]
机构
[1] Ctr Physiopathol Toulouse Purpan, INSERM, Toulouse, France
[2] Univ Toulouse 3, Dept Pathol, F-31062 Toulouse, France
[3] Hop Rangueil, Dept Pathol, Toulouse, France
[4] Purpan Hosp, Cytogenet Lab, Toulouse, France
[5] Univ Estadual Campinas, Fac Med Sci, Dept Pathol, Campinas, Brazil
[6] Hosp Canc, Dept Pathol, Sao Paulo, Brazil
关键词
BCL2; c-MYC; fluorescence in situ hybridization; FISH; bone; B-cell lymphoma;
D O I
10.1309/CMPGPYTMFRM6RVQR
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We selected a series of 63 primary diffuse large B-cell lymphomas (DLBCLs) of bone collected in tissue microarrays from centers in France and Brazil. These cases were classified according to the expression of antigens associated with germinal center (GC; n = 42) or non-GC (n = 21) stages of B-cell differentiation. By fluorescence in situ hybridization, we found a substantial number of cases with a rearrangement of BCL2 (9132) and c-MYC (n = 3), whereas the PAX5, BCL6, BCL1/cyclin D1, and ALK genes were in germline configuration. It is interesting that I case, with a GC phenotype, showed dual B CL2 and c-MYC rearrangement. The majority of the cases with rearrangements were of the GC phenotype. These results, associated with the lack of BCL6 rearrangement, suggest that bone DLBCL represents a specific group within extranodal B-cell lymphomas.
引用
收藏
页码:723 / 726
页数:4
相关论文
共 50 条
  • [41] BCL2 and MYC Protein Expression in Primary Testicular Diffuse Large B Cell Lymphoma
    Gascoyne, R. D.
    Tan, K. L.
    Ben-Neriah, S.
    Savage, K. J.
    Telio, D.
    Hung, T.
    Connors, J. M.
    Scott, D. W.
    Steidl, C.
    Slack, G. W.
    LABORATORY INVESTIGATION, 2012, 92 : 336A - 336A
  • [42] Diffuse large B-cell lymphoma with MYC gene rearrangements Current perspective on treatment of diffuse large B-cell lymphoma with MYC gene rearrangements; case series and review of the literature
    de Jonge, A. V.
    Roosma, T. J. A.
    Houtenbos, I.
    Vasmel, W. L. E.
    van de Hem, K.
    de Boer, J. P.
    van Maanen, T.
    Lindauer-van der Werf, G.
    Beeker, A.
    Timmers, G. J.
    Schaar, C. G.
    Soesan, M.
    Poddighe, P. J.
    de Jong, D.
    Chamuleau, M. E. D.
    EUROPEAN JOURNAL OF CANCER, 2016, 55 : 140 - 146
  • [43] Heterogeneity of diffuse large B-cell lymphoma with c-myc gene abnormalities.
    Nakamura, N
    Kuze, T
    Ohno, H
    Nakamura, S
    Nomura, K
    Taniwaki, M
    Ohshima, K
    Yoshino, T
    Tomita, N
    Abe, M
    BLOOD, 2003, 102 (11) : 888A - 888A
  • [44] De novo CD5-positive primary cardiac diffuse large B-cell lymphoma coexpressing C-myc and BCL2 in an immunocompetent adult
    Xiao, Yangyang
    Cai, Yuyan
    Tang, Hong
    Xiao, Xijun
    EUROPEAN HEART JOURNAL, 2017, 38 (24) : 1937 - 1937
  • [45] MYC and BCL2 Gene Rearrangements in Comparison to MYC and BCL2 Protein Expression in AIDS-Related Diffuse Large B Cell Lymphomas
    Nam, Anna
    Mathew, Susan
    Liu, Yen-Chun
    Chadburn, Amy
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146
  • [46] Noninvasive Detection of BCL2, BCL6, and MYC Translocations in Diffuse Large B-Cell Lymphoma
    Kurtz, David M.
    Scherer, Florian
    Newman, Aaron M.
    Craig, Alexander
    Jin, Michael
    Stehr, Henning
    Chabon, Jacob J.
    Esfahani, Mohammad
    Liu, Chih Long
    Zhou, Li
    Glover, Cynthia
    Visser, Brendan C.
    Poultsides, George
    Advani, Ranjana H.
    Maeda, Lauren S.
    Gupta, Neel K.
    Levy, Ronald
    Ohgami, Robert S.
    Davis, R. Eric
    Kunder, Christian A.
    Westin, Jason R.
    Diehn, Maximilian
    Alizadeh, Ash A.
    BLOOD, 2016, 128 (22)
  • [47] Prognostic Implications of MYC and BCL2 Expression in Primary Diffuse Large B-cell Lymphoma of the Central Nervous System
    Kim, Sehui
    Nam, Soo Jeong
    Kwon, Dohee
    Kim, Hannah
    Kim, Tae Min
    Heo, Dae Seog
    Park, Sung Hye
    Kim, Chul Woo
    Jeon, Yoon Kyung
    MODERN PATHOLOGY, 2016, 29 : 356A - 356A
  • [48] Prognostic Implications of MYC and BCL2 Expression in Primary Diffuse Large B-cell Lymphoma of the Central Nervous System
    Kim, Sehui
    Nam, Soo Jeong
    Kwon, Dohee
    Kim, Hannah
    Kim, Tae Min
    Heo, Dae Seog
    Park, Sung Hye
    Kim, Chul Woo
    Jeon, Yoon Kyung
    LABORATORY INVESTIGATION, 2016, 96 : 356A - 356A
  • [49] BCL2 Is Highly Mutated In Diffuse Large B-Cell Lymphoma
    Schuetz, Johanna M.
    Johnson, Nathalie A.
    Morin, Ryan D.
    Hirst, Martin
    Zhao, Yongjun
    Tam, Angela
    Moore, Richard
    Zeng, Thomas
    Marra, Marco A.
    Connors, Joseph M.
    Brooks-Wilson, Angela R.
    Gascoyne, Randy D.
    BLOOD, 2010, 116 (21) : 1702 - 1703
  • [50] Impact of Cell of Origin, MYC/BCL2 Dual Expression and MYC Rearrangements in Diffuse Large B-Cell Lymphoma Patients Treated with Combined Modality Therapy
    Augustyn, A.
    Gunther, J. R.
    Medeiros, L. J.
    Milgrom, S. A.
    Nastoupil, L.
    Neelapu, S. S.
    Nair, R.
    Li, S.
    Ok, C. Y.
    Steiner, R. E.
    Iyer, S. P.
    Ahmed, S.
    Westin, J.
    Rodriguez, M. A.
    Pasalic, D.
    Fayad, L.
    Samaniego, F.
    Dabaja, B.
    Pinnix, C. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S248 - S248